BIOMAT Database Logo BIOMAT Database Logo

Antithrombin III Toyama: a congenital antithrombin III abnormality with recurrent thrombophlebitis. 1985

K Takahashi, and S Kondo, and N Sakuragawa

UI MeSH Term Description Entries
D007123 Immunoelectrophoresis, Two-Dimensional Immunoelectrophoresis in which a second electrophoretic transport is performed on the initially separated antigen fragments into an antibody-containing medium in a direction perpendicular to the first electrophoresis. Immunoelectrophoresis, Crossed,Immunoelectrophoresis, 2-D,Immunoelectrophoresis, 2D,2-D Immunoelectrophoresis,2D Immunoelectrophoresis,Crossed Immunoelectrophoresis,Immunoelectrophoresis, 2 D,Immunoelectrophoresis, Two Dimensional,Two-Dimensional Immunoelectrophoresis
D007525 Isoelectric Focusing Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point. Electrofocusing,Focusing, Isoelectric
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002846 Chromatography, Affinity A chromatographic technique that utilizes the ability of biological molecules, often ANTIBODIES, to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Bioaffinity,Immunochromatography,Affinity Chromatography,Bioaffinity Chromatography
D005170 Factor X Storage-stable glycoprotein blood coagulation factor that can be activated to factor Xa by both the intrinsic and extrinsic pathways. A deficiency of factor X, sometimes called Stuart-Prower factor deficiency, may lead to a systemic coagulation disorder. Autoprothrombin III,Coagulation Factor X,Stuart Factor,Stuart-Prower Factor,Blood Coagulation Factor X,Factor 10,Factor Ten,Stuart Prower Factor,Factor X, Coagulation
D005260 Female Females
D006025 Glycosaminoglycans Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine (see ACETYLGLUCOSAMINE) or N-acetylgalactosamine (see ACETYLGALACTOSAMINE). Glycosaminoglycan,Mucopolysaccharides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I

Related Publications

K Takahashi, and S Kondo, and N Sakuragawa
[Hereditary abnormalities of antithrombin III in patients with recurrent thrombophlebitis].
January 1986, Medicinski arhiv,
K Takahashi, and S Kondo, and N Sakuragawa
Isolation and characterization of a hereditary abnormal antithrombin III 'Antithrombin III Toyama'.
July 1983, Thrombosis research,
K Takahashi, and S Kondo, and N Sakuragawa
Congenital antithrombin III abnormality and cerebral arterial thrombosis.
August 1991, Stroke,
K Takahashi, and S Kondo, and N Sakuragawa
[Platelet function in a family with abnormal antithrombin III-Toyama].
March 1983, [Rinsho ketsueki] The Japanese journal of clinical hematology,
K Takahashi, and S Kondo, and N Sakuragawa
[The diagnosis of congenital antithrombin III deficiency and abnormality].
May 1987, Rinsho byori. The Japanese journal of clinical pathology,
K Takahashi, and S Kondo, and N Sakuragawa
[Severe pulmonary embolism and recurrent thrombophlebitis caused by hereditary antithrombin III deficiency].
August 1979, Archives des maladies du coeur et des vaisseaux,
K Takahashi, and S Kondo, and N Sakuragawa
Purification and partial characterization of a hereditary abnormal antithrombin III fraction of a patient with recurrent thrombophlebitis.
October 1980, Thrombosis and haemostasis,
K Takahashi, and S Kondo, and N Sakuragawa
Congenital antithrombin III deficient neonate treated with antithrombin III concentrates.
May 1993, Thrombosis research,
K Takahashi, and S Kondo, and N Sakuragawa
Interaction of abnormal antithrombin-III Toyama with cultured porcine aortic endothelial cells.
April 1988, Thrombosis research,
K Takahashi, and S Kondo, and N Sakuragawa
Antithrombin III Padua: a "new" congenital antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic disease.
January 1983, Folia haematologica (Leipzig, Germany : 1928),
Copied contents to your clipboard!